Article Details

UW Medicine offers second drug for early Alzheimer's

Retrieved on: 2025-04-25 16:44:10

Tags for this article:

Click the tags to see associated articles and topics

UW Medicine offers second drug for early Alzheimer's. View article details on hiswai:

Summary

The article discusses the use of Alzheimer's drugs donanemab and lecanemab, which are anti-amyloid antibodies targeting amyloid plaques in the brain, slowing cognitive decline in patients with mild cognitive impairment. Tags relate to Alzheimer's disease and associated treatment and diagnostic methods.

Article found on: newsroom.uw.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo